James E. Patrick

1.7k total citations
50 papers, 1.4k citations indexed

About

James E. Patrick is a scholar working on Pharmacology, Pharmacology and Analytical Chemistry. According to data from OpenAlex, James E. Patrick has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 16 papers in Pharmacology and 12 papers in Analytical Chemistry. Recurrent topics in James E. Patrick's work include Pharmacogenetics and Drug Metabolism (17 papers), Analytical Methods in Pharmaceuticals (11 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). James E. Patrick is often cited by papers focused on Pharmacogenetics and Drug Metabolism (17 papers), Analytical Methods in Pharmaceuticals (11 papers) and Antibiotics Pharmacokinetics and Efficacy (10 papers). James E. Patrick collaborates with scholars based in United States, China and United Kingdom. James E. Patrick's co-authors include Kevin B. Alton, Swapan K. Chowdhury, Robert Iannucci, Shmuel Zbáida, Anima Ghosal, Paul Statkevich, Melton B. Affrime, Teddy Kosoglou, S. K. Chowdhury and Ragu Ramanathan and has published in prestigious journals such as Analytical Chemistry, The American Journal of Cardiology and Journal of Chromatography A.

In The Last Decade

James E. Patrick

49 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
James E. Patrick 325 277 269 228 193 50 1.4k
Mitchell N. Cayen 349 1.1× 473 1.7× 261 1.0× 221 1.0× 125 0.6× 77 1.6k
Hiroyasu Ogata 307 0.9× 259 0.9× 153 0.6× 432 1.9× 134 0.7× 100 1.7k
Wen Chyi Shyu 219 0.7× 408 1.5× 88 0.3× 270 1.2× 132 0.7× 78 1.6k
Robert P. Clement 373 1.1× 342 1.2× 120 0.4× 548 2.4× 157 0.8× 35 1.5k
Kwang‐il Kwon 201 0.6× 454 1.6× 95 0.4× 228 1.0× 124 0.6× 89 1.3k
Michael A. Wynalda 251 0.8× 507 1.8× 103 0.4× 173 0.8× 130 0.7× 33 1.7k
Shigeo Ikegawa 186 0.6× 556 2.0× 198 0.7× 444 1.9× 237 1.2× 97 1.3k
H K Kroemer 336 1.0× 337 1.2× 103 0.4× 371 1.6× 88 0.5× 50 1.4k
Mingkang Zhong 235 0.7× 448 1.6× 126 0.5× 258 1.1× 71 0.4× 100 1.7k
Lars Knutson 384 1.2× 454 1.6× 375 1.4× 838 3.7× 203 1.1× 63 2.6k

Countries citing papers authored by James E. Patrick

Since Specialization
Citations

This map shows the geographic impact of James E. Patrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Patrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Patrick more than expected).

Fields of papers citing papers by James E. Patrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Patrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Patrick. The network helps show where James E. Patrick may publish in the future.

Co-authorship network of co-authors of James E. Patrick

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Patrick. A scholar is included among the top collaborators of James E. Patrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Patrick. James E. Patrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramanathan, Ragu, Larisa Reyderman, S. K. Chowdhury, et al.. (2007). Disposition of desloratadine in healthy volunteers. Xenobiotica. 37(7). 770–787. 22 indexed citations
2.
Ramanathan, Ragu, Larisa Reyderman, Kenneth Kulmatycki, et al.. (2007). Disposition of loratadine in healthy volunteers. Xenobiotica. 37(7). 753–769. 28 indexed citations
3.
Ramanathan, Ragu, et al.. (2005). Metabolism and excretion of loratadine in male and female mice, rats and monkeys. Xenobiotica. 35(2). 155–189. 24 indexed citations
4.
Ghosal, Anima, Yuan Yuan, Robert Iannucci, et al.. (2004). IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF POSACONAZOLE (NOXAFIL). Drug Metabolism and Disposition. 32(2). 267–271. 139 indexed citations
5.
Ghosal, Anima, Yuan Yuan, Robert Iannucci, et al.. (2004). IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF EZETIMIBE (ZETIA). Drug Metabolism and Disposition. 32(3). 314–320. 108 indexed citations
6.
Reyderman, Larisa, Paul Statkevich, C. Mohan Thonoor, et al.. (2004). Disposition and pharmacokinetics of temozolomide in rat. Xenobiotica. 34(5). 487–500. 50 indexed citations
7.
Kosoglou, Teddy, Ingo Meyer, Enrico P. Veltri, et al.. (2002). Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin. British Journal of Clinical Pharmacology. 54(3). 309–319. 91 indexed citations
8.
Ezzet, Farkad, David Wexler, Paul Statkevich, et al.. (2001). The Plasma Concentration and LDL-C Relationship in Patients Receiving Ezetimibe. The Journal of Clinical Pharmacology. 41(9). 943–949. 49 indexed citations
9.
10.
Alton, Kevin B., Teddy Kosoglou, Susan S. Baker, et al.. (1998). Disposition of 14C-eptifibatide after intravenous administration to healthy men. Clinical Therapeutics. 20(2). 307–323. 32 indexed citations
11.
Kosoglou, Teddy, David J. Kazierad, Jerome J. Schentag, et al.. (1995). Effect of Food on the Oral Bioavailability of Isosorbide‐5‐Mononitrate Administered as an Extended‐Release Tablet. The Journal of Clinical Pharmacology. 35(2). 151–158. 9 indexed citations
12.
13.
Wagner, John G., Derek Ganes, Kamal K. Midha, et al.. (1991). Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam. Journal of Pharmacokinetics and Biopharmaceutics. 19(4). 413–455. 10 indexed citations
14.
Tenero, David M., Michael B. Bottorff, Bruce D. Given, et al.. (1989). Pharmacokinetics and pharmacodynamics of dilevalol. Clinical Pharmacology & Therapeutics. 46(6). 648–656. 6 indexed citations
15.
Given, Bruce D., George Perentesis, Jerry Herron, et al.. (1989). Antihypertensive effect of dilevalol is directly related to dose and plasma concentrations. The American Journal of Cardiology. 63(19). I12–I16. 6 indexed citations
16.
Radwanski, Elaine, et al.. (1988). Secretion of Dilevalol in Breast Milk. The Journal of Clinical Pharmacology. 28(5). 448–453. 7 indexed citations
17.
Alton, Kevin B., et al.. (1988). High-performance liquid chromatographic assay for dilevalol in human plasma and urine using a PRP-1 column and fluorimetric detection. Journal of Chromatography B Biomedical Sciences and Applications. 425(2). 363–372. 9 indexed citations
18.
Powell, Mark L., et al.. (1987). Comparative steady state bioavailability of conventional and controlled‐release formulations of albuterol. Biopharmaceutics & Drug Disposition. 8(5). 461–468. 14 indexed citations
19.
Sybertz, Edmund J., Robert W. Watkins, Ho Sam Ahn, et al.. (1987). Pharmacologic, Metabolic, and Toxicologic Profile of Spirapril (SCH 33844), a New Angiotensin Converting Inhibitor. Journal of Cardiovascular Pharmacology. 10. 105–108. 15 indexed citations
20.
Alton, Kevin B., et al.. (1975). BIOTRANSFORMATION OF A 1,5-BENZODIAZEPINE, TRIFLUBAZAM, BY MAN. Drug Metabolism and Disposition. 3(5). 352–360. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitchell N. Cayen Breakdown of academic impact, for papers by Hiroyasu Ogata Breakdown of academic impact, for papers by Wen Chyi Shyu Breakdown of academic impact, for papers by Robert P. Clement Breakdown of academic impact, for papers by Kwang‐il Kwon Breakdown of academic impact, for papers by Michael A. Wynalda Breakdown of academic impact, for papers by Shigeo Ikegawa Breakdown of academic impact, for papers by H K Kroemer Breakdown of academic impact, for papers by Mingkang Zhong Breakdown of academic impact, for papers by Lars Knutson
Rankless by CCL
2026